WA
WALD.US Waldencast plc
- Market cap
- USD 112M
- P/E
- -
- P/B
- 0.29x
- ROE
- -108.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is WALD.US undervalued?
Graham numberThe Graham number of Waldencast plc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Waldencast plc fundamental analysis
No fundamental analysis for Waldencast plc yet.
Waldencast plc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Waldencast plc
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation…
Full company profileWaldencast plc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Waldencast plc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 94.4M | 142M | 218M | 274M | 272M | 104M |
| Gross Profit | 65.3M | 87.4M | 142M | 132M | 124M | 20.0M |
| Operating Income | 528K | -1.63M | -81.9M | -58.6M | -61.7M | -164M |
| EBITDA | 13.9M | 15.0M | -33.5M | 28.6M | -2.49M | -128M |
| Net Income | -2.37M | -19.6M | -90.0M | -42.4M | -230M | -425M |
| EPS | -0.20 | -0.45 | -0.89 | -0.39 | -2.01 | -3.58 |
| Balance Sheet | ||||||
| Total Assets | 167K | 185M | 1.04B | 976M | 816M | 647M |
| Total Liabilities | 178K | 145M | 273M | 246M | 316M | 256M |
| Shareholders' Equity | -11.0K | 39.2M | 625M | 662M | 462M | 391M |
| Cash & Short-term Investments | 0.00 | 12.8M | 22.6M | 14.8M | 31.9M | 7.82M |
| Total Debt | - | 119M | 178M | 182M | 149M | 149M |
| Cash Flow | ||||||
| Operating Cash Flow | -7.43M | 3.53M | -29.8M | -8.82M | -12.8M | -40.4M |
| Capital Expenditure | 1.71M | 1.29M | 2.05M | 3.01M | 3.43M | 0.00 |
| Free Cash Flow | -9.14M | 2.24M | -31.8M | -11.8M | -16.2M | -40.4M |
| Ratios | ||||||
| ROE | - | -49.9% | -14.4% | -6.4% | -49.7% | -108.7% |
| ROA | -1,420.9% | -10.6% | -8.6% | -4.3% | -28.1% | -65.8% |
| Net Profit Margin | -2.5% | -13.7% | -41.2% | -15.5% | -84.4% | -407.4% |
| Debt to Equity | - | 3.03x | 0.28x | 0.27x | 0.32x | 0.38x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Waldencast plc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | USD 2.00M | 0.05 | - |
| 2020 | USD 2.04M | 0.18 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:1 on Jul 28, 2022.
Who owns Waldencast plc
- Insiders 51.61%
- Institutions 24.52%
- Public & others 23.87%
- Shares outstanding 119M
- Free float 47.2M
Top funds holding WALD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| More Stacx FIM C Priv IE | 119K | 0.09% | 0.00% | Jul 2026 |
| Fidelity Nasdaq Composite Index | 74.3K | 0.06% | 0.00% | Aug 2026 |
| Goldman Sachs Absolute Ret Trckr Instl | 37.2K | 0.03% | +143.22% | Jun 2026 |
| Perenne Mulligan FIM C Priv | 27.8K | 0.02% | 0.00% | Sep 2026 |
| GS Absolute Ret Trkr I Acc EUR Hdg | 5.67K | 0.00% | 0.00% | Aug 2026 |
| AXAWF Global Dynamic Allocation I CapUSD | 9.00 | 0.00% | 0.00% | Feb 2026 |
Top institutions holding WALD.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Zeno Equity Partners LLP | 12.3M | 9.63% | 0.00% | Jun 2026 |
| Milestones Administradora de Recursos LTDA. | 2.43M | 1.91% | 0.00% | Jun 2026 |
| Stoic Point Capital Management LLC | 1.61M | 1.27% | -1.49% | Jun 2026 |
| Millennium Management LLC | 577K | 0.45% | 0.00% | Jun 2026 |
| Schonfeld Strategic Advisors LLC | 462K | 0.36% | 0.00% | Jun 2026 |
| Jane Street Group LLC | 429K | 0.34% | 0.00% | Jun 2026 |
| Beartown Capital Management, LLC | 300K | 0.24% | 0.00% | Jun 2026 |
| AQR Capital Management LLC | 272K | 0.21% | +453.50% | Jun 2026 |
| Qube Research & Technologies | 169K | 0.13% | 0.00% | Jun 2026 |
| Aster Capital Management (DIFC) Ltd | 132K | 0.10% | 0.00% | Jun 2026 |
| The Goldman Sachs Group Inc | 100.0K | 0.08% | -41.52% | Jun 2026 |
| UBS Group AG | 88.1K | 0.07% | +6.22% | Jun 2026 |
| HRT FINANCIAL LLC | 73.4K | 0.06% | 0.00% | Jun 2026 |
| XTX Topco Ltd | 72.5K | 0.06% | 0.00% | Jun 2026 |
| SmartHarvest Portfolios, LLC | 64.8K | 0.05% | 0.00% | Jun 2026 |
| Geode Capital Management, LLC | 52.9K | 0.04% | -91.82% | Jun 2026 |
| Point72 Asset Management, L.P. | 45.6K | 0.04% | 0.00% | Jun 2026 |
| FORTIS CAPITAL ADVISORS, LLC | 41.8K | 0.03% | 0.00% | Jun 2026 |
| Belpointe Asset Management LLC | 41.8K | 0.03% | 0.00% | Jun 2026 |
| Citigroup Inc | 37.1K | 0.03% | +1,551.69% | Jun 2026 |
Waldencast plc company profile
- Company name
- Waldencast plc
- Ticker
- WALD.US
- ISIN
- JE00BPG99318
- Exchange
- USA Stocks
- Listed since
- May 12, 2021
- Sector
- Consumer Defensive
- Industry
- Software
- Employees
- 367
- Fiscal year end
- December
- Address
- 81 Fulham Road, London, United Kingdom, SW3 6RD
- Phone
- 44 20 3196 0264
- Website
- waldencast.com
About Waldencast plc
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.
Waldencast plc management
2- Mr. Felipe DutraChairman of the Board, Principal Executive & Financial Officer & Interim CEO · born 1965
- Ms. Elisabeth MilanGeneral Counsel